京都大学は、日本の国立大学である。京都府京都市に本部を置く。略称は京大。

During the past decade, Kyoto University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyoto University" #1 sponsor was "Baxter Healthcare Corporation" with 1 trials, followed by "Kyoto University" with 1 trials sponsored, "National Center of Neurology and Psychiatry, Japan" with 1 trials sponsored, "Ophthalmic PDT Study Group" with 1 trials sponsored and "Tokai University" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyoto University" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Asahi Intech" with 1 trials as a collaborator, "Hiroshima University" with 1 trials as a collaborator, "Japan Lifeline" with 1 trials as a collaborator and "Kaneka Medical America LLC" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Kyoto University" are "Age Related Macular Degeneration" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Anesthesia" (1 trials), "Anxiety Disorders" (1 trials) and "Coronary Occlusion" (1 trials). Many other conditions were trialed in "Kyoto University" in a lesser frequency.

Most popular intervention types in "Kyoto University" are "Drug" (3 trials), "Behavioral" (1 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bosutinib (Phase 1 part)" (1 trials), "Bosutinib (Phase 2 part)" (1 trials), "Mindfulness-based stress management program" (1 trials), "Neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel" (1 trials) and "Ocular photodynamic therapy with verteporfin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kyoto University" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kyoto University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kyoto University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kyoto University, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Kyoto University has several departments that took part in Clinical trials: "Division of Cardiology, Kyoto University Hospital" - 14 trials, "Kyoto University Hospital; Breast Surgery" - 5 trials, "Department of Gastroenterology and Hepatology, Kyoto University Hospital" - 2 trials, "Epidemiological and Clinical Research Information Network" - 2 trials